These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 15266036

  • 1. Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes.
    Delles C, Schneider MP, Oehmer S, Fleischmann I, Fleischmann EF, Schmieder RE.
    Nephrol Dial Transplant; 2004 Oct; 19(10):2513-8. PubMed ID: 15266036
    [Abstract] [Full Text] [Related]

  • 2. Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes.
    Ritt M, Ott C, Delles C, Schneider MP, Schmieder RE.
    Pharmacogenet Genomics; 2008 Aug; 18(8):699-707. PubMed ID: 18622262
    [Abstract] [Full Text] [Related]

  • 3. Gender is related to alterations of renal endothelial function in type 2 diabetes.
    Schneider MP, Ritt M, Raff U, Ott C, Schmieder RE.
    Nephrol Dial Transplant; 2009 Nov; 24(11):3354-9. PubMed ID: 19567476
    [Abstract] [Full Text] [Related]

  • 4. Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk.
    Schlaich MP, Oehmer S, Schneider MP, Delles C, Schmidt BM, Schmieder RE.
    Atherosclerosis; 2007 May; 192(1):155-60. PubMed ID: 16765359
    [Abstract] [Full Text] [Related]

  • 5. Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress.
    Schäufele TG, Schlaich MP, Delles C, Klingbeil AU, Fleischmann EH, Schmieder RE.
    Kidney Int; 2006 Sep; 70(6):1177-81. PubMed ID: 16883318
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.
    Eur J Pharmacol; 2005 Mar 21; 511(1):53-64. PubMed ID: 15777779
    [Abstract] [Full Text] [Related]

  • 7. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN, Nielsen EH, Pedersen RS, Svendsen KB, Pedersen EB.
    Am J Hypertens; 2007 Mar 21; 20(3):287-95. PubMed ID: 17324742
    [Abstract] [Full Text] [Related]

  • 8. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.
    Anderson RA, Evans LM, Ellis GR, Khan N, Morris K, Jackson SK, Rees A, Lewis MJ, Frenneaux MP.
    Diabet Med; 2006 Mar 21; 23(3):258-64. PubMed ID: 16492208
    [Abstract] [Full Text] [Related]

  • 9. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
    Woodman RJ, Playford DA, Watts GF.
    Diabetes Res Clin Pract; 2006 Jan 21; 71(1):59-67. PubMed ID: 16029909
    [Abstract] [Full Text] [Related]

  • 10. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients.
    Taddei S, Versari D, Cipriano A, Ghiadoni L, Galetta F, Franzoni F, Magagna A, Virdis A, Salvetti A.
    J Am Coll Cardiol; 2006 Aug 01; 48(3):508-15. PubMed ID: 16875977
    [Abstract] [Full Text] [Related]

  • 11. Rapid non-genomic effects of aldosterone on the renal vasculature.
    Schmidt BM.
    Steroids; 2008 Oct 01; 73(9-10):961-5. PubMed ID: 18242654
    [Abstract] [Full Text] [Related]

  • 12. L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
    Cassone Faldetta M, Laurenti O, Desideri G, Bravi MC, De Luca O, Marinucci MC, De Mattia G, Ferri C.
    Diabetologia; 2002 Aug 01; 45(8):1120-7. PubMed ID: 12189442
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
    Brunini T, Moss M, Siqueira M, Meirelles L, Rozentul A, Mann G, Ellory J, Soares de Moura R, Mendes-Ribeiro A.
    Clin Exp Pharmacol Physiol; 2004 Oct 01; 31(10):738-40. PubMed ID: 15554917
    [Abstract] [Full Text] [Related]

  • 14. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress.
    Clapp BR, Hingorani AD, Kharbanda RK, Mohamed-Ali V, Stephens JW, Vallance P, MacAllister RJ.
    Cardiovasc Res; 2004 Oct 01; 64(1):172-8. PubMed ID: 15364625
    [Abstract] [Full Text] [Related]

  • 15. The effect of flutamide on systemic and renal hemodynamics in Zucker diabetic rats: paradoxic renal vasodilator response to endothelin-1 and TXA2 receptor activation in female sex.
    Ajayi AA, Fidelis P.
    J Cardiovasc Pharmacol; 2006 Nov 01; 48(5):191-8. PubMed ID: 17110800
    [Abstract] [Full Text] [Related]

  • 16. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
    Tran D, Lowy A, Howes JB, Howes LG.
    Diabetes Obes Metab; 2005 May 01; 7(3):273-81. PubMed ID: 15811145
    [Abstract] [Full Text] [Related]

  • 17. L-arginine-induced growth hormone secretion is not influenced by co-infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine in healthy men.
    Fisker S, Nielsen S, Ebdrup L, Bech JN, Christiansen JS, Pedersen EB, Jørgensen JO.
    Growth Horm IGF Res; 1999 Feb 01; 9(1):69-73. PubMed ID: 10207510
    [Abstract] [Full Text] [Related]

  • 18. Assessment of endothelial function of the renal vasculature in human subjects.
    Delles C, Jacobi J, Schlaich MP, John S, Schmieder RE.
    Am J Hypertens; 2002 Jan 01; 15(1 Pt 1):3-9. PubMed ID: 11824856
    [Abstract] [Full Text] [Related]

  • 19. Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase.
    Dixon LJ, Hughes SM, Rooney K, Madden A, Devine A, Leahey W, Henry W, Johnston GD, McVeigh GE.
    Am J Hypertens; 2005 Jun 01; 18(6):839-43. PubMed ID: 15925745
    [Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.
    Virdis A, Colucci R, Fornai M, Blandizzi C, Duranti E, Pinto S, Bernardini N, Segnani C, Antonioli L, Taddei S, Salvetti A, Del Tacca M.
    J Pharmacol Exp Ther; 2005 Mar 01; 312(3):945-53. PubMed ID: 15547110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.